|
Influence of denosumab on disseminated tumor cells (DTC) in the bone marrow of breast cancer (BC) patients with neoadjuvant treatment: A GeparX translational substudy. |
|
|
Consulting or Advisory Role - Amgen; AstraZeneca; MSD; Novartis; Roche; Tesaro |
Research Funding - Amgen; Novartis |
Travel, Accommodations, Expenses - AstraZeneca; PharmaMar; Roche |
|
|
Honoraria - Amgen; AstraZeneca; Genomic Health; MSD Oncology; Myriad Genetics; Novartis/Pfizer; Pfizer; Roche; Sonoscape |
|
|
No Relationships to Disclose |
|
|
Honoraria - Amgen; Clovis Oncology; MSD; Novartis; Pfizer; Roche; Tesaro; Teva |
Consulting or Advisory Role - Amgen; MSD; Roche; Tesaro |
Travel, Accommodations, Expenses - Celgene; MSD; Pfizer; Roche |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Hologic; Olympus |
Travel, Accommodations, Expenses - Dialog Service GmbH; German Breast Group; iMed Conference; Medconcept; Medtronic; Mentor; Mylan; Pfizer |
|
|
Consulting or Advisory Role - Amgen; AstraZeneca; Celgene; Daiichi Sankyo; MSD Oncology; Novartis; Pfizer; Roche |
Travel, Accommodations, Expenses - Roche |
|
|
Stock and Other Ownership Interests - Sividon Diagnostics |
Honoraria - Amgen; Novartis; Pfizer; Roche; Teva |
Consulting or Advisory Role - Amgen; Daiichi Sankyo; MSD Oncology |
Patents, Royalties, Other Intellectual Property - Patent application: EP18209672 - cancer immunotherapy; Patent application: EP20150702464 - therapy response; VMScope digital pathology software |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Tesaro |
Travel, Accommodations, Expenses - AstraZeneca |
|
|
Honoraria - Amgen; AstraZeneca; Lilly; Novartis; Pfizer; Roche Pharma AG; Vifor Pharma |
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Lilly; Novartis; Pfizer; Roche Pharma AG; Vifor Pharma |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Chugai Pharma |
Consulting or Advisory Role - Abbvie (Inst); Amgen (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Lilly (Inst); Merck KGaA (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Seagen (Inst) |
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Celgene (Inst); Cepheid (Inst); Daiichi Sankyo (Inst); Immunomedics (Inst); Myriad Genetics (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Seagen (Inst); Vifor Pharma (Inst) |
Patents, Royalties, Other Intellectual Property - Patent Pending EP14153692.0 (Inst) |